UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Molecular basis of MED12 in the pathogenesis of uterine fibroids
Molecular basis of MED12 in the pathogenesis of uterine fibroids is a funding opportunity from UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, up to 363682, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
PROJECT SUMMARY/ABSTRACT Uterine fibroids (UFs) are the most important benign neoplastic threat to women’s health worldwide. As no long- term non-invasive treatment option exists for UFs, deeper insight into tumor etiology is key to develop more effective therapies. Accordingly, this proposal is impactful as it…